Entry Detail



General Information

Database ID:exR0090455
RNA Name:hsa-miR-708-5p
RNA Type:miRNA
Chromosome:chr11
Starnd:-
Coordinate:
Start Site(bp):79402077End Site(bp):79402099
External Links:hsa-miR-708-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ANKRD52
chr12
56237807
56258384
-
TUB
chr11
8019244
8106112
+
ERG28
chr14
75649791
75660876
-
KIAA1522
chr1
32741830
32774970
+
RGMA
chr15
93035273
93089204
-
RARG
chr12
53210567
53232980
-
GPCPD1
chr20
5544439
5611006
-
ZBTB7B
chr1
155002630
155018522
+
GLYR1
chr16
4803203
4847288
-
SMARCD1
chr12
50085200
50100707
+
UBE2Z
chr17
48908407
48929056
+
SEH1L
chr18
12947133
12987536
+
LONRF2
chr2
100271875
100322501
-
ENSA
chr1
150600851
150629612
-
PTMS
chr12
6765516
6770952
+
ATXN2L
chr16
28823035
28837237
+
FAM102A
chr9
127940582
127980989
-
TOB2
chr22
41433494
41446801
-
SLC31A1
chr9
113221544
113264492
+
PTPN23
chr3
47381011
47413435
+
TEX261
chr2
70985942
70994873
-
E2F4
chr16
67192155
67198918
+
N4BP1
chr16
48538726
48620148
-
FOXK1
chr7
4682295
4771442
+
DYRK1A
chr21
37365573
37526358
+
E2F6
chr2
11444375
11466177
-
CPSF2
chr14
92121969
92172145
+
NAPA
chr19
47487637
47515091
-
MAPK1
chr22
21754500
21867680
-
SMYD1
chr2
88067825
88113384
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0001146
chr20
34241449
34246936
-
hsa_circ_0001164
chr20
45891031
45923523
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009065.4
chr16
2119207
2120248
+
AC016876.2
chr17
7581964
7584086
-
AC026362.1
chr12
122975320
122982907
+
AC118758.3
chr7
56809214
56848800
-
MALAT1
chr11
65497688
65506516
+
NEAT1
chr11
65422774
65445540
+
OIP5-AS1
chr15
41283990
41309737
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.